Aggregation of tau and alpha-synuclein: towards a therapeutic target in neurodegenerative diseases - Oxford Talks

Aggregation of tau and alpha-synuclein: towards a therapeutic target in neurodegenerative diseases

Abstract not yet added

Date: 9 January 2019, 13:30 (Wednesday, 0th week, Hilary 2019)
Venue:
NDM Building
Headington OX3 7FZ
See location on maps.ox

Details: Seminar Room
Speaker: Professor Maria Grazia Spillantini FRS (Department of Clinical Neurosciences, University of Cambridge)
Organising department: Target Discovery Institute
Organisers: Kate Humphrey (University of Oxford), Dr John Davis (Alzheimer’s Research UK Oxford Drug Discovery Institute), Elena Di Daniel, Head of Biology (Oxford Drug Discovery Institute, University of Oxford)
Organiser contact email address: kate.humphrey@ndm.ox.ac.uk
Host: Kate Humphrey (University of Oxford)
Part of: ARUK Oxford Drug Discovery Institute Seminar Series
Booking required?: Not required
Cost: Free
Audience: Members of the University only
Editor: Kate Humphrey